Track the 코스맥스비티아이 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 코스맥스비티아이 has recorded 55 public disclosures. Market capitalisation: €191.6bn. The latest transaction was disclosed on 26 June 2026 (Other). Among the most active insiders: 서성석. All data is accessible without an account.
55
Insider Decl.
n/a
Thresholds
n/a
41 ops.
Buy Volume
n/a
2 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,223 of 28,803 companies
55.8
score / 100
Value
67
Quality
45
FCF yld1.1%
Earn yld13%
EV/EBITDA9.5x
ROE25%
Gross mgn21%
Net mgn4.5%
Debt/EBITDA6.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Cosmax BTI is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and manufacturing of pharmaceutical and cosmetic products.